Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 17-24

  Zhang, Peng ^a   Zhao, Ming ^a   Liang, Gongping ^a   Yin, Guangliang ^b   Huang, Dan ^b   Su, Fengxia ^b   Zhai, Hanyue ^a   Wang, Litao ^a   Su, Yuwen ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

Author keywords

MeDIP Seq; PDCD5; Psoriasis; TIMP2

Indexed keywords

GENOMIC DNA; MESSENGER RNA; PROGRAMMED CELL DEATH 5; PROGRAMMED DEATH 1 RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE SEQUENCE; GENOME; HUMAN; IMMUNE SYSTEM; IMMUNOPRECIPITATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN DEFECT; UPREGULATION;

ADULT; APOPTOSIS REGULATORY PROTEINS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSORIASIS; SEQUENCE ANALYSIS, DNA; SKIN; SULFITES; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 84875960454     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.01.001     Document Type: Article

References (33)

1. Griffiths C.E.M., Camp R.D.R., Barker J.N.W.N. Psoriasis. Rook's textbook of dermatology 2005, vol. 35:1-69. 7th ed.
2. Christophers E. Psoriasis-epidemiology and clinical spectrum. Clinical and Experimental Dermatology 2001, 26:314-320.
3. Gaspari A.A. Innate and adaptive immunity and the pathophysiology of psoriasis. Journal of the American Academy of Dermatology 2006, 54:S67-S80.
4. Das R.P., Jain A.K., Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian Journal of Dermatology 2009, 54:7-12.
5. Krueger G.G., Duvic M. Epidemiology of psoriasis: clinical issues. The Journal of Investigative Dermatology 1994, 102:14S-18S.
6. Peters B.P., Weissman F.G., Gill M.A. Pathophysiology and treatment of psoriasis. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-system Pharmacists 2000, 57:645-659. [quiz 60-61].
7. Tsankov N., Angelova I., Kazandjieva J. Drug-induced psoriasis. Recognition and management. American Journal of Clinical Dermatology 2000, 1:159-165.
8. Baker B.S., Garioch J.J., Hardman C., Powles A., Fry L. Induction of cutaneous lymphocyte-associated antigen expression by group A streptococcal antigens in psoriasis. Archives of Dermatological Research 1997, 289:671-676.
9. Selmi C., Lu Q., Humble M.C. Heritability versus the role of the environment in autoimmunity. Journal of Autoimmunity 2012, 39:249-252.
10. Miller F.W., Pollard K.M., Parks C.G., Germolec D.R., Leung P.S., Selmi C., et al. Criteria for environmentally associated autoimmune diseases. Journal of Autoimmunity 2012, 39:253-258.
11. Selmi C., Leung P.S., Sherr D.H., Diaz M., Nyland J.F., Monestier M., et al. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. Journal of Autoimmunity 2012, 39:272-284.
12. Robertson K.D. DNA methylation and human disease. Nature Reviews Genetics 2005, 6:597-610.
13. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
14. Fraga M.F., Esteller M. DNA methylation: a profile of methods and applications. Biotechniques 2002, 33. [632, 634, 636-49].
15. Mardis E.R. Next-generation DNA sequencing methods. Annual Review of Genomics and Human Genetics 2008, 9:387-402.
16. Shendure J., Ji H. Next-generation DNA sequencing. Nature Biotechnology 2008, 26:1135-1145.
17. Li N., Ye M., Li Y., Yan Z., Butcher L.M., Sun J., et al. Whole genome DNA methylation analysis based on high throughput sequencing technology. Methods 2010, 52:203-212.
18. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., et al. Model-based analysis of ChIP-Seq (MACS). Genome Biology 2008, 9:R137.
19. Roberson E.D., Liu Y., Ryan C., Joyce C.E., Duan S., Cao L., et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. The Journal of Investigative Dermatology 2012, 132:583-592.
20. Maunakea A.K., Nagarajan R.P., Bilenky M., Ballinger T.J., D'Souza C., Fouse S.D., et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466:253-257.
21. Zhang P., Su Y., Chen H., Zhao M., Lu Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. Journal of Dermatological Science 2010, 60:40-42.
22. Chen M., Chen Z.Q., Cui P.G., Yao X., Li Y.M., Li A.S., et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. British Journal of Dermatology 2008, 158:987-993.
23. Spinola M., Meyer P., Kammerer S., Falvella F.S., Boettger M.B., Hoyal C.R., et al. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2006, 24:1672-1678.
24. Li S.J., Yu J., Zhao X.F., Jiang Y., Liu Z.J., Yu X.G. PDCD5 induces the apoptosis of human prostate cancer cells PC-3M-1E8. Zhonghua nan ke xue = National Journal of Andrology 2007, 13:979-982.
25. Du Y.J., Xiong L., Lou Y., Tan W.L., Zheng S.B. Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer. Chinese Medical Sciences Journal = Chung-kuo i hsueh k'o hsueh tsa chih/Chinese Academy of Medical Sciences 2009, 24:241-245.
26. Liu Z.H., Zhang D., Li K.M., Liao Q.P. Expression of PDCD5 in tissues of normal cervix, CIN I-III and cervical cancer. Beijing da xue xue bao Yi xue ban = Journal of Peking University Health Sciences 2004, 36:407-410.
27. Ruan G.R., Zhao H.S., Chang Y., Li J.L., Qin Y.Z., Liu Y.R., et al. Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis: An International Journal on Programmed Cell Death 2008, 13:641-648.
28. Su D.M., Zhang Q., Wang X., He P., Zhu Y.J., Zhao J., et al. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy. Molecular Cancer Therapeutics 2009, 8:1292-1304.
29. Zhao X.Y., Liu H.W., Wei M.J. Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma. Beijing da xue xue bao Yi xue ban = Journal of Peking University Health Sciences 2005, 37:429-432.
30. Yan L., Qi H.Y., Wen W.J., Wang H., Zhu T.J. Study of the expression of apoptosis-related molecule PDCD5 in the skin lesions of psoriasis. Chinese Journal of Dermatology 2004, 37:215-217.
31. Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Critical Reviews in Oncology/Hematology 2004, 49:187-198.
32. Bertaux B., Hornebeck W., Eisen A.Z., Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. The Journal of Investigative Dermatology 1991, 97:679-685.
33. Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Letters 1992, 298:29-32.